| Code | Description | Claims | Beneficiaries | Total Paid |
| 99205 |
Prolong outpt/office vis |
1,385 |
1,380 |
$51K |
| 99215 |
Prolong outpt/office vis |
2,956 |
2,747 |
$49K |
| 93000 |
|
407 |
397 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
387 |
382 |
$8K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,250 |
4,879 |
$7K |
| 94010 |
|
76 |
74 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
74 |
73 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,189 |
1,163 |
$1K |
| 90674 |
|
62 |
62 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
80 |
79 |
$1K |
| 99385 |
|
218 |
214 |
$339.26 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
702 |
645 |
$259.46 |
| 96127 |
|
295 |
269 |
$184.31 |
| 99407 |
|
487 |
458 |
$173.81 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,494 |
1,401 |
$156.34 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
31 |
30 |
$124.68 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$83.04 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
354 |
340 |
$58.77 |
| 81001 |
|
13 |
13 |
$15.00 |
| 1220F |
|
1,940 |
1,743 |
$0.36 |
| G9920 |
Screening performed and negative |
512 |
466 |
$0.35 |
| 96160 |
|
782 |
713 |
$0.32 |
| 1036F |
|
2,654 |
2,437 |
$0.31 |
| H0049 |
Alcohol and/or drug screening |
1,002 |
933 |
$0.24 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
149 |
139 |
$0.19 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
423 |
374 |
$0.19 |
| 80053 |
Comprehensive metabolic panel |
484 |
448 |
$0.17 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
179 |
170 |
$0.06 |
| G0402 |
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment |
334 |
317 |
$0.06 |
| 99408 |
|
51 |
47 |
$0.05 |
| 4004F |
|
276 |
256 |
$0.05 |
| 1160F |
|
171 |
115 |
$0.02 |
| 3079F |
|
858 |
793 |
$0.02 |
| 3075F |
|
720 |
680 |
$0.02 |
| 3078F |
|
511 |
492 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
441 |
405 |
$0.00 |
| 99483 |
Prolong outpt/office vis |
45 |
42 |
$0.00 |
| 3077F |
|
129 |
126 |
$0.00 |
| 3051F |
|
113 |
107 |
$0.00 |
| 1159F |
|
61 |
56 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
15 |
15 |
$0.00 |
| 3074F |
|
488 |
457 |
$0.00 |
| 3044F |
|
272 |
250 |
$0.00 |
| 3017F |
|
48 |
47 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
80 |
78 |
$0.00 |
| 2016F |
|
87 |
83 |
$0.00 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
18 |
14 |
$0.00 |
| 99406 |
|
29 |
26 |
$0.00 |
| 93922 |
|
22 |
22 |
$0.00 |
| 3080F |
|
16 |
15 |
$0.00 |
| 82043 |
|
13 |
12 |
$0.00 |